observed enhanced expression of PRC2 complex, PI3K/AKT and NOTCH pathway genes, and PI3K/AKT pharmacological inhibition delayed tumour growth and NE transformation in EGFR‐mutant patient‐derived xenografts. The gene discussed is PIK3CA; the disease is neoplasm.